AMGN
Amgen Inc. · BMV:AMGN
8,381.00 MXN0.00 0.00%
Amgen Inc. (BMV:AMGN) last traded at 8,381.00 MXN, unchanged on the day. Over the past year the stock is up 58.13%. Its 52-week range is 5,537.96 to 8,420.00. It is in the Health Technology sector (Biotechnology).
Key statistics
Open8,381.00
Day range8,381.00 – 8,381.00
52-week range5,537.96 – 8,420.00
Volume1
Average volume (10 days)540
Market cap (USD)251.94 B
P/E29.74
EPS (TTM) (USD)16.10
Dividend yield2.13%
Beta (1 year)−0.1105
Revenue (TTM) (USD)38.20 B
Employees31.50 K
Performance
−0.11%1 week
+15.44%1 month
+31.78%3 months
+38.30%6 months
+41.21%Year to date
+58.13%1 year
Technical rating
Buy
Daily summary of 11 oscillators and 15 moving averages. See every indicator
Analysts’ target
7,620.26 MXN
The average 1-year price target, −9.08% from the last price. See the forecast
Latest headlines
- Amgen (AMGN) reports Q3: everything you need to know ahead of earningsStock Story · 02 Nov 2026
- Jobs, Midterm Elections, Apple, Palantir, McDonald's, Moderna, and More to Watch This Week — Barrons.comDow Jones Newswires · 01 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Big Homes, Big Loans — Barrons.comDow Jones Newswires · 30 Oct 2026
- Catalyst watch: Election drama, jobs report, Apple and McDonald's in the earnings confessionalSeeking Alpha · 30 Oct 2026
- Steve Jobs' Son Says GLP-1 Weight Loss Drugs Could Be Among Most Important Medicines Ever, With Potential Impact on CancerBenzinga · 29 Oct 2026
- Amgen Q3 Earnings: Will Strong Drug Sales Offset Headwinds?Zacks · 28 Oct 2026
- FDA warns Amgen over cancer drug promotional videoReuters · 28 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.